Icu Medical INC/DE splits its revenue into 7 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Infusion Consumables at $1.1 billion, 50% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2,183
|
2,231
|
2,382
|
2,259
|
2,280
|
1,316
|
1,271
|
1,266
|
1,400
|
1,293
|
379
|
| Infusion Consumables |
1,151
+5.3%
share 52.7%
|
1,109
+6.8%
share 49.7%
|
1,039
+7.2%
share 43.6%
|
969
-0.6%
share 42.9%
|
975
+75.6%
share 42.8%
|
555
+17.2%
share 42.2%
|
474
-0.8%
share 37.3%
|
478
-1.1%
share 37.7%
|
483
+32.1%
share 34.5%
|
366
share 28.3%
|
—
|
| Infusion Systems |
737
+8.5%
share 33.8%
|
684
+4.9%
share 30.7%
|
652
+3.7%
share 27.4%
|
629
+1.9%
share 27.8%
|
617
+75.2%
share 27.1%
|
352
-2.0%
share 26.8%
|
360
+9.6%
share 28.3%
|
328
-7.7%
share 25.9%
|
355
+22.5%
share 25.4%
|
290
share 22.5%
|
—
|
| Vital Care |
295
-46.2%
share 13.5%
|
438
-36.6%
share 19.6%
|
691
+4.5%
share 29.0%
|
661
-3.9%
share 29.3%
|
688
share 30.2%
|
—
|
—
|
—
|
—
|
—
|
—
|
| IV Solutions |
—
|
—
|
—
|
—
|
—
|
359
-7.6%
share 27.3%
|
389
-6.3%
share 30.6%
|
415
-18.3%
share 32.8%
|
508
-2.7%
share 36.3%
|
522
share 40.4%
|
—
|
| Other Revenue |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
65
share 5.0%
|
—
|
| Critical Care |
—
|
—
|
—
|
—
|
—
|
49
+1.5%
share 3.7%
|
49
+7.2%
share 3.8%
|
45
-15.3%
share 3.6%
|
54
+7.1%
share 3.8%
|
50
share 3.9%
|
—
|
| Product And Service Other |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
share 0.0%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ICUI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Clemente, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 883984
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.